Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story.
In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it’s diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma.
DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Multiple myeloma
- Amyloidosis
- Autologous stem cell transplantation
- CAR T-cell therapy
- Immunotherapy fact sheet
- Clinical Trial Support Center
Additional Blood Cancer United Support Resources:
- Information Specialists
- Financial support
- Online Chat
- Free Nutrition Consultations
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Support groups
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Advocacy and Public Policy
- Patient Community
- Mental Health Resources
Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson.
The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first appeared on The Bloodline with Blood Cancer United Podcast.
POWERED BY BLUBRRY
